ELI
NKTR icon

Empire Life Investments’s Nektar Therapeutics NKTR Stock Holding History

Empire Life Investments’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,730
Closed -$228K – 97
2022
Q4 		$228K Sell
6,730
-82
-1% -$3.97K 0.02% 92
2022
Q3 		$327K Buy
6,812
+238
+4% +$14.2K 0.02% 90
2022
Q2 		$375K Buy
6,574
+125
+2% +$7.89K 0.03% 92
2022
Q1 		$521K Buy
6,449
+33
+0.5% +$4.88K 0.03% 90
2021
Q4 		$1.3M Buy
6,416
+15
+0.2% +$3.25K 0.08% 84
2021
Q3 		$1.73M Buy
6,401
+23
+0.4% +$5.53K 0.11% 76
2021
Q2 		$1.64M Buy
6,378
+100
+2% +$27.7K 0.11% 75
2021
Q1 		$1.88M Sell
6,278
-133
-2% -$41.4K 0.13% 78
2020
Q4 		$1.64M Sell
6,411
-33
-0.5% -$8.53K 0.12% 83
2020
Q3 		$1.6M Buy
6,444
+20
+0.3% +$6.29K 0.13% 73
2020
Q2 		$2.23M Sell
6,424
-426
-6% -$133K 0.2% 61
2020
Q1 		$1.83M Buy
6,850
+106
+2% +$32.8K 0.17% 73
2019
Q4 		$2.18M Buy
6,744
+34
+0.5% +$9.86K 0.17% 67
2019
Q3 		$1.83M Buy
6,710
+391
+6% +$143K 0.15% 73
2019
Q2 		$3.37M Buy
6,319
+90
+1% +$45.1K 0.27% 71
2019
Q1 		$3.14M Buy
6,229
+2,492
+67% +$1.48M 0.26% 68
2018
Q4 		$1.84M Buy
3,737
+52
+1% +$31.4K 0.17% 73
2018
Q3 		$3.37M Sell
3,685
-25
-0.7% -$21.3K 0.26% 77
2018
Q2 		$2.72M Buy
+3,710
New +$4.28M 0.2% 81

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Empire Life Investments's NKTR Position: Q1 2023 in Review

Empire Life Investments sold out of Nektar Therapeutics (NKTR) in Q1 2023, closing a stake of 6,730 shares — an estimated $228K sold.

Empire Life Investments first reported a position in NKTR in Q2 2018 and held it in 19 quarters. The position peaked at $3.37M in Q2 2019. 194 funds tracked by Wall St. Rank hold NKTR as of Q1 2023.

  • Empire Life Investments reported no remaining Nektar Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Empire Life Investments sold 6,730 Nektar Therapeutics shares in Q1 2023, an estimated $228K.
  • Empire Life Investments first reported a position in Nektar Therapeutics in Q2 2018 and held it in 19 quarters.
  • Empire Life Investments's Nektar Therapeutics position peaked at $3.37M in Q2 2019.
  • 194 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2023.

Based on Empire Life Investments's 13F filing for Q1 2023, filed 8 May 2023.